Literature DB >> 14641513

Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases.

L Magy1, B Chassande, T Maisonobe, P Bouche, J-M Vallat, J-M Léger.   

Abstract

Peripheral neuropathy has been widely reported in patients with monoclonal gammopathy (MG), more frequently immunoglobulin M (IgM) or IgG than IgA. Nevertheless, it remains unclear whether this association has clinical or pathogenic relevance. In order to clarify the possible role of IgG/IgA MG in neuropathy, we studied the clinical and electrophysiological features of 15 consecutive patients with polyneuropathy and IgG/IgA-MG, and compared them to those of 40 patients with polyneuropathy associated with IgM-MG, previously reported. Nine middle-aged patients (60%) had a chronic progressive or relapsing demyelinating polyneuropathy (DP) that was clinically and electrophysiologically indistinguishable from classic chronic inflammatory demyelinating polyneuropathy (CIDP) and frequently responded to immunosuppressive treatments, both characteristics supporting a dysimmune process. Six older patients (40%) had a chronic axonal distal polyneuropathy similar to the so-called chronic cryptogenic sensory polyneuropathy: there was no clear relationship with the MG in these patients and the response to immunosuppressive treatments was poor. Several features allowed us to distinguish between polyneuropathies associated with IgG/IgA-MG (IgG/IgA-PN) considered together and polyneuropathies associated with IgM-MG (IgM-PN). In the first group, the proportion of patients with a predominantly sensory clinical picture (27%) was less than that in the second group (75%), and there were fewer changes in nerve conduction studies. In addition, we found that the nine patients with DP associated with IgG/IgA-MG (IgG/IgA-DP) differed from the 31 with DP associated with IgM-MG (IgM-DP): clinical and electrophysiological studies clearly showed that the demyelinating pattern was more heterogeneous in IgG/IgA-DP than in IgM-DP. The spectrum of polyneuropathies associated with IgG/IgA-MG is heterogeneous, including DP, which is similar to classic CIDP, and axonal polyneuropathy, in which the pathogenic role of the MG remains elusive. In addition, IgG/IgA-DP differ from IgM-DP on clinical and electrophysiological grounds, suggesting probable different physiopathological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641513     DOI: 10.1046/j.1468-1331.2003.00687.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

Review 1.  Treatment of dys-immune neuropathies.

Authors:  Eduardo Nobile-Orazio
Journal:  J Neurol       Date:  2005-04       Impact factor: 4.849

Review 2.  An update on monoclonal gammopathy and neuropathy.

Authors:  Sindhu Ramchandren; Richard A Lewis
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

3.  Analyzing Relationship Between Monoclonal Gammopathy of Undetermined Significance (MGUS) with Different Types of Neuropathy: An Observational Study.

Authors:  Shahzaib Nabi; Pushpinderdeep Kahlon; Farshid Bozorgnia; Adeel Arshad; Akmam Saleem; Philip Kuriakose
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-28       Impact factor: 0.900

Review 4.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

Review 5.  Treatment for IgG and IgA paraproteinaemic neuropathy.

Authors:  Abraham C J Stork; Michael P T Lunn; Eduardo Nobile-Orazio; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2015-03-24

Review 6.  Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors:  Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-12       Impact factor: 10.154

7.  Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.

Authors:  Mark Stettner; Lena Hinrichs; Rainer Guthoff; Silja Bairov; Ioannis N Petropoulos; Clemens Warnke; Hans-Peter Hartung; Rayaz A Malik; Bernd C Kieseier
Journal:  Ann Clin Transl Neurol       Date:  2015-12-28       Impact factor: 4.511

8.  Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report.

Authors:  Stéphane Mathis; Jérôme Franques; Laurence Richard; Jean-Michel Vallat
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 9.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849

10.  Polyneuropathy associated with IgA paraproteinemia and amyloidosis: a case report and literature review.

Authors:  Yunsook Jhang; Jung Ju Lee; Jong-Moo Park; Ja-Seong Koo; Byung-Kun Kim; Ohyun Kwon
Journal:  J Clin Neurol       Date:  2007-06-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.